Authors:
COUROUCE AM
NOEL L
BARIN F
ELGHOUZZI MH
LUNEL F
NORTH ML
SMILOVICI W
Citation: Am. Courouce et al., A COMPARATIVE-EVALUATION OF THE SENSITIVITY OF 5 ANTI-HEPATITIS-C VIRUS IMMUNOBLOT ASSAYS, Vox sanguinis, 74(4), 1998, pp. 217-224
Citation: Ml. North et Am. Courouce, RESULTS OF 32 MONTHS CONTINUOUS CONTROL O F THE DETECTION KITS FOR ANTI-HIV, ANTI-HTLV ANTIBODIES AND HBS-ANTIGEN USED MOST COMMONLY IN TRANSFUSION BIOLOGY, Transfusion clinique et biologique, 4(2), 1997, pp. 185-201
Authors:
BARIN F
COUROUCE AM
PILLONEL J
BUZELAY L
BAUDELOT J
BOTTE C
CHAMARET S
DURAND F
ELGHOUZZI MH
LEMAIRE JM
MAISONNEUVE P
MANIEZ M
MONCHARMONT P
NOEL L
NORTH ML
PIQUET Y
ROUZIOUX C
SMILOVICI W
TIRTAINE C
Citation: F. Barin et al., INCREASING DIVERSITY OF HIV-1(M) SEROTYPES IN FRENCH BLOOD-DONORS OVER A 10-YEAR PERIOD (1985-1995), AIDS, 11(12), 1997, pp. 1503-1508
Citation: Ml. North et al., PERFORMANCE OF KITS FOR THE DETECTION OF ANTI-HTLV-I ANTI-HTLV-II ANTIBODIES COMMERCIALIZED IN FRANCE IN 1995/, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 163-163
Authors:
REY D
HASSAIRI N
PARTISANI M
JACQUEMIN C
KEMPF G
DEMAUTORT E
NORTH ML
LANG JM
Citation: D. Rey et al., SEROPREVALENCE OF HEPATITIS-C VIRUS (WITH 2ND-GENERATION ELISA AND RIBA TESTS) AMONG HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PATIENTS, Medecine et maladies infectieuses, 25(11), 1995, pp. 1125-1131
Authors:
WAJCMAN H
GIRODON E
PROME D
NORTH ML
PLASSA F
DUWIG I
KISTER J
BERGERAT JP
OBERLING F
LAMPERT E
LONSDORFER J
GOOSSENS M
GALACTEROS F
Citation: H. Wajcman et al., GERMLINE MOSAICISM FOR AN ALANINE TO VALINE SUBSTITUTION AT RESIDUE-BETA-140 IN HEMOGLOBIN PUTTELANGE, A NEW VARIANT WITH HIGH OXYGEN-AFFINITY, Human genetics, 96(6), 1995, pp. 711-716
Authors:
JANOT C
COUROUCE AM
BARIN F
LUNELFABIANI F
TREPO C
BOTTE C
BOUDART D
COTTE C
ELGHOUZZI MH
JULLIEN AM
LEMAIRE JM
LUNEL F
MAISONNEUVE P
MANIEZ M
MATTLINGER B
MENAULT M
MONCHARMONT P
MOUILLOT L
NORTH ML
OPOLON P
PIQUET Y
SMILOVICI W
TREPO C
Citation: C. Janot et al., ELISA SCREENING-TEST FOR HCV ANTIBODIES - SENSITIVITY ANALYSIS WITH 5ASSAYS USED IN FRANCE, Transfusion clinique et biologique, 1(4), 1994, pp. 295-301
Authors:
JANOT C
BARIN F
BOUDART D
COTTE C
COUROUCE AM
ELGHOUZZI MH
JULLIEN AM
LEMAIRE JM
MAISONNEUVE P
MANIEZ M
MATTLINGER B
MENAULT M
MONCHARMONT P
MOUILLOT L
NORTH ML
OPOLON P
PIQUET Y
SMILOVICI W
TREPO C
Citation: C. Janot et al., ELISA KITS FOR SCREENING ANTI-HCV ANTIBOD IES, Transfusion clinique et biologique, 1(1), 1994, pp. 47-48
Authors:
ROUZIOUX C
BARIN F
BAUDELOT J
CHAMARET S
COUROUCE AM
ELGHOUZZI MH
DURAND F
JANOT C
LEMAIRE JM
MAISONNEUVE P
MANIEZ M
MONCHARMONT P
MOUILLOT L
NORTH ML
PIQUET Y
SMILOVICI W
TIRTAINE C
Citation: C. Rouzioux et al., EVALUATION OF HIV SCREENING-TESTS, Transfusion clinique et biologique, 1(1), 1994, pp. 49-49
Authors:
COUROUCE AM
BAUDELOT J
DURAND F
ELGHOUZZI MH
JANOT C
LEMAIRE JM
MANIEZ M
MESNIER F
MONCHARMONT J
NOEL L
NORTH ML
SMILOVICI W
TIRTAINE C
BARIN F
CHAMARET S
MOUILLOT L
ROUZIOUX C
Citation: Am. Courouce et al., ANTI-HIV IN BLOOD-DONORS FROM 1990 TO 199 2 - SEROPREVALENCE, RESIDUAL RISK ESTIMATED AND EPIDEMIOLOGY, Revue francaise de transfusion et d'hemobiologie, 36(4), 1993, pp. 327-337